Hepatotoxicity After CDK 4/6 Inhibitor Initiation in the Treatment of Hormone-Positive Metastatic Breast Cancer

Cancer cells proliferate using various mechanisms. One mechanism of preventing tumor cell growth is blockade of the cyclin-dependent kinase (CDK) 4/6 axis. Multiple CDK 4/6 inhibitors - ribociclib, palbociclib, and abemaciclib - have significantly improved progression-free survival rates. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wani, Kashmira, Patel, Kunj, Dabak, Vrushali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289899/
https://www.ncbi.nlm.nih.gov/pubmed/37363122
http://dx.doi.org/10.7759/cureus.40871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289899/
https://www.ncbi.nlm.nih.gov/pubmed/37363122
http://dx.doi.org/10.7759/cureus.40871

Ejemplares similares